Skip to main navigation Skip to search Skip to main content

Clinical Performance Study Protocol for Use of VENTANA PD-L1 (SP263) CDx Assay in AstraZeneca Study D7984C000002 (eVOLVE-Cervical)

Project: Research

Project Details

StatusFinished
Effective start/end date11/13/24 → 11/12/25

Funding

  • AstraZeneca AB: $41,871.73